Overview
- NADA temporarily suspended Alex Schwazer after tests from a German road race in April 2026 reportedly found erythropoietin, or EPO, in both his urine and blood samples.
- Schwazer initially refused to request a B‑sample analysis unless a separately stored 'third vial' of residual urine delivered on April 26 was also examined, but his lawyer says he has now been persuaded to proceed without that condition.
- Requesting the B sample starts the standard confirmation step in anti‑doping cases, because a positive B result typically triggers formal disciplinary processes under WADA rules while a negative B can overturn the finding.
- The 'third vial' is a separate residual urine sample whose handling and custody have been cited by Schwazer as central to his mistrust of testing procedures given his long legal dispute after a 2012 case.
- The outcome of the B‑sample test will determine whether the provisional suspension is upheld and whether Schwazer faces longer sanctions or can mount further legal appeals, and it will shape how his public claims of testing failures are received.